4/11/25 18:12 | 4/9/25 | TECX | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT | | P.m | 2,299 | 16.20 | 0 | 142 | 2 | 6,024 | M | | | | | | | | | | | | | | |
4/9/25 17:38 | 4/7/25 | TECX | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT | | P | 8,550 | 17.10 | 0 | 500 | 9 | 5,882 | M | | | | | | | | | | | | | | |
2/7/25 16:21 | 2/5/25 | TECX | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT | | P | 40,000 | 50.68 | 0 | 789 | 17 | 5,382 | M | | | | | | | | | | | | | | |
2/7/25 16:19 | 2/5/25 | TECX | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | MA | O | CFO | P | 250 | 54.14 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
10/24/24 17:04 | 10/22/24 | TECX | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT | | P | 10,077 | 33.59 | 0 | 300 | 7 | 4,593 | D | | | | | | | | | | | | | | |
9/26/24 18:15 | 9/26/24 | TECX | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT | | P | 1,441 | 28.82 | 0 | 50 | 1 | 4,293 | M | | | | | | | | | | | | | | |
5/15/24 11:21 | 5/13/24 | AVRO | Health | BioPrd | Biological Products, (No Diag | Leonard Braden Michael | IN | T | | P.m | 971 | 1.27 | 0 | 767 | 17 | 5,168 | I | | | | | | | | | | | | | | |
7/8/21 16:21 | 7/7/21 | AVRO | Health | BioPrd | Biological Products, (No Diag | Vickers Philip J. | MA | D | | P | 40 | 8.35 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
2/18/21 19:06 | 2/17/21 | AVRO | Health | BioPrd | Biological Products, (No Diag | Donenberg Phillip B. | MA | D | | P | 23 | 11.71 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |
7/23/19 16:09 | 7/19/19 | AVRO | Health | BioPrd | Biological Products, (No Diag | Atlas Venture Fund X, L.P. | MA | T | | P | 15,000 | 18.50 | 0 | 811 | 17 | 5,567 | I | | | | | | | | | | | | | | |
7/23/19 16:09 | 7/19/19 | AVRO | Health | BioPrd | Biological Products, (No Diag | Booth Bruce | MA | D | | P | 15,000 | 18.50 | 0 | 811 | 17 | 5,567 | I | | | | | | | | | | | | | | |